Evidence map›Paper›PMID 22927064›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2012

Sham surgery controls in Parkinson's disease clinical trials: views of participants.

Scott Y H Kim, Raymond De Vries, Robert G Holloway, Renee Wilson, Sonali Parnami, H Myra Kim, Samuel Frank, Karl Kieburtz

Abstract readMulticenter Study
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Patient and Caregiver Experiences of Participating in Parkinson's Disease Clinical Trials: A Systematic Review of Qualitative Studies.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Scott Y H KimDepartment of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA. scottkim@med.umich.edu
Raymond De Vries
Robert G Holloway
Renee Wilson
Sonali Parnami
H Myra Kim
Samuel Frank
Karl Kieburtz

Funding

UNIVERSITY OF ROCHESTER'S RESEARCH ASSOCIATE ORGANIZATIONUL1RR024160 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$38.7M
Therapeutic Misconception and the Ethics of Sham Surgery Controls in PD ResearchR01NS062770 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DE VRIES, RAYMOND G · 2009 to 2012
$1.4M
NCRR NIH HHS UL1 RR024160NINDS NIH HHS R01 NS062770NINDS NIH HHS R01-NS062770
6 · The paper itself

Abstract

backgroundSham surgery controls are increasingly used in neurosurgical clinical trials in Parkinson's disease (PD) but remain controversial. We interviewed participants of such trials, specifically examining their understanding and attitudes regarding sham surgery.

methodsWe conducted semistructured qualitative interviews with participants of 3 sham surgery-controlled trials for PD, focusing on their understanding of sham design, their reactions to it, its impact on decision making, and their understanding of posttrial availability of the experimental intervention and its impact on decisions to participate.

resultsAll subjects (n = 90) understood the 2-arm design; most (86%) described the procedural differences between the arms accurately. Ninety-two percent referred to scientific or regulatory reasons as rationales for the sham control, with 62% specifically referring to the placebo effect. Ninety-one percent said posttrial availability of the experimental intervention had a strong (48%) or some (43%) influence on their decision to participate, but only 68% understood the conditions for posttrial availability.

conclusionsMost subjects in sham surgery-controlled PD trials comprehend the sham surgery design and its rationale. Although there is room for improvement, most subjects of sham surgery trials appear to be adequately informed.

Indexed as

AttitudeClinical Trials as TopicFemaleHumansMaleParkinson DiseaseResearch DesignSurveys and Questionnaires

Identifiers

PMID22927064
PMCPMC3703438

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.